How multisystem inflammatory syndrome in children discriminated from Kawasaki disease: a differentiating score based

Ali Sobh1, Doaa Mosad Mosa2, Nada Khaled3

  • 1Department of Pediatrics, Mansoura University Children's Hospital, Mansoura University Faculty of Medicine, Mansoura, Egypt.

Clinical Rheumatology
|November 21, 2022
PubMed

Insights

Differentiating multisystem inflammatory syndrome in children (MIS-C) from Kawasaki disease (KD) is challenging. A new scoring model using clinical and lab data helps distinguish MIS-C from KD, aiding timely treatment decisions.

Area of Science:

  • Pediatric rheumatology
  • Infectious diseases
  • Critical care medicine

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) shares diagnostic overlap with Kawasaki disease (KD), affecting 25-50% of MIS-C patients.
  • Accurate differentiation is crucial due to time-sensitive management protocols for both conditions.
  • Clinical practice faces challenges in distinguishing MIS-C from KD, impacting patient care.

Purpose of the Study:

  • To develop a predictive model for differentiating MIS-C from KD.
  • To identify key clinical and laboratory features that distinguish between MIS-C and KD.
  • To aid clinicians in making timely and accurate treatment decisions.

Main Methods:

  • Retrospective analysis of clinical and laboratory data from hospitalized patients under 18 with MIS-C or KD.
  • Comparison of demographic, clinical, and laboratory profiles between MIS-C and KD cohorts.
  • Development of a discrimination score using logistic regression analysis.

Main Results:

  • MIS-C patients exhibited a higher prevalence of abdominal pain, vomiting, and cervical lymphadenopathy compared to KD patients.
  • Elevated liver enzymes (AST, ALT) and serum creatinine, along with a lower platelet count nadir, were observed in MIS-C.
  • A predictive scoring model was generated, achieving an area under the curve of 0.70 for distinguishing MIS-C from KD.

Conclusions:

  • A novel prediction model based on clinical and laboratory findings effectively differentiates MIS-C from KD.
  • The model provides valuable support for clinicians in treatment decision-making for pediatric inflammatory conditions.
  • Key differentiating factors include gastrointestinal symptoms, cervical lymphadenopathy, elevated liver enzymes, and lower platelet counts in MIS-C.
Abstract